Moreover, the inhibition of VCAN amplifies the anti-tumour effectiveness of endostatin by mitigating the induced accumulation of myeloid-derived suppressor cells (MDSCs), tumour-associated macrophages (TAMs), and inflammatory cytokines within the TME [270]. This evidence concerns the gene VCAN and neoplasm.